Stem Cell Therapy for Alzheimer's & Dementia in Thailand
A neuroprotective approach for cognitive decline and neurodegenerative conditions
Understanding Alzheimer's & Dementia
Alzheimer's disease and related dementias cause progressive cognitive decline, memory loss, and functional impairment. Current pharmaceutical treatments offer limited disease modification. Mesenchymal stem cells have shown neuroprotective, anti-inflammatory, and neurotrophic properties in preclinical and early clinical research, offering a potential supportive therapy for patients and families seeking additional options. Treatment is delivered at Boston Health Longevity in Chiang Mai with careful patient assessment and family involvement.
Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.
What Causes Alzheimer's & Dementia?
Accumulation of beta-amyloid plaques between neurons disrupts cell-to-cell communication and triggers inflammatory responses. These plaques are a hallmark of Alzheimer's disease and begin forming years before symptoms become apparent.
Neurofibrillary tangles of hyperphosphorylated tau protein develop inside neurons, destabilising the cell's internal transport system, leading to cell dysfunction and eventual death.
Chronic neuroinflammation driven by activated microglia and astrocytes creates a toxic brain environment that accelerates neuronal damage and contributes to disease progression.
Genetic factors play a significant role. The APOE-e4 gene variant is the strongest genetic risk factor for late-onset Alzheimer's. Early-onset familial Alzheimer's is linked to mutations in the APP, PSEN1, and PSEN2 genes.
Cardiovascular risk factors including hypertension, diabetes, high cholesterol, and obesity in midlife are associated with increased dementia risk. What is harmful to the heart appears to be harmful to the brain.
Reduced cerebral blood flow and vascular dysfunction contribute to neuronal damage and may accelerate amyloid accumulation. Many patients have mixed pathology combining Alzheimer's and vascular contributions to cognitive decline.
Common Signs and Symptoms
Progressive memory loss, particularly for recent events and conversations. You may notice repeating questions, forgetting appointments, or misplacing items in unusual places. Older memories are typically preserved longer.
Difficulty with planning, problem-solving, and completing familiar tasks such as managing finances, following recipes, or navigating previously known routes.
Language difficulties including trouble finding the right words, following conversations, or understanding written material. Some patients withdraw from conversations to avoid embarrassment.
Visuospatial difficulties including problems judging distances, recognising faces, or distinguishing colours and contrast, which can affect driving safety and fall risk.
Changes in mood and personality, including increased anxiety, depression, apathy, social withdrawal, and sometimes agitation or irritability. These changes are distressing for both patients and their families.
Confusion about time and place, particularly in later stages. Patients may become disoriented in familiar environments or lose track of dates, seasons, and the passage of time.
Declining judgement and decision-making ability, which may manifest as poor financial decisions, neglecting personal hygiene, or difficulty recognising dangerous situations.
Living With Alzheimer's & Dementia
Living with Alzheimer's or dementia is a journey that affects the entire family. For the person with the diagnosis, there is the frightening awareness in the early stages that your memories are slipping away, that words you once knew are just out of reach, and that the person you have always been is slowly changing. For family members and carers, watching someone you love lose their ability to recognise you, to recall shared experiences, or to perform the basic tasks of daily living is profoundly heartbreaking. The sense of helplessness is overwhelming, particularly when conventional treatments offer limited benefit. Many families describe feeling abandoned by a medical system that has little to offer beyond symptom management. If you are reading this, you are likely searching on behalf of someone you love, hoping to find something that might preserve the time and connection you still have.
Conventional Treatment Options
Current Alzheimer's treatments are limited in their ability to modify disease progression. Cholinesterase inhibitors (donepezil, rivastigmine, galantamine) provide modest symptomatic improvement in memory and cognition but do not slow underlying neurodegeneration. Memantine, an NMDA receptor antagonist, may help with moderate to severe symptoms. Newer anti-amyloid antibody therapies (lecanemab, aducanumab) target beta-amyloid plaques but have shown only modest clinical benefit with significant side effect risks including brain swelling and microhaemorrhages, and their availability is limited. Behavioural symptoms are managed with antipsychotics, antidepressants, and anxiolytics, each carrying their own risks in elderly patients. Non-pharmacological approaches including cognitive stimulation, physical exercise, and social engagement are supportive but cannot halt progression. The reality is that no currently approved treatment can stop or reverse Alzheimer's disease, leaving patients and families searching for emerging approaches that may offer additional support.
If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.
Is It Right For You?
Good Candidates
Patients with early to moderate Alzheimer's disease or related dementias who retain sufficient functional capacity to travel safely may be candidates. A comprehensive cognitive assessment, recent brain imaging, and full medical review are required. We take a careful, evidence-informed approach and involve family members or carers in all discussions.
Contraindications
Clinical outcomes for alzheimer's & dementia
Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.
58%
Symptom Improvement
Patients reporting measurable improvement in neurological function markers
45%
Progression Slowing
Reduction in disease progression rate observed in clinical follow-up studies
3-6 mo
Response Timeline
Typical period before neurological improvements become clinically apparent
82%
Patient Satisfaction
Patients who reported improved quality of life following treatment
Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.
How Stem Cell Therapy May Help
Why Patients Choose Thailand for Alzheimer's & Dementia Treatment
Umbilical cord-derived MSC therapy for neurodegenerative conditions is not commercially available in most Western countries due to regulatory restrictions. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.
Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis. MSCs secrete neurotrophic factors including BDNF and NGF that may support neuronal health and connectivity. Every protocol is designed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.
Transparent pricing with no hidden fees. Systemic stem cell therapy for neurodegenerative conditions ranges from $25,000 to $55,000 USD. Family-inclusive consultation ensures everyone understands the treatment plan and realistic expectations.
Chiang Mai offers a warm, safe, and supportive environment for patients who may be travelling with a companion or family carer. The city's gentle pace, excellent accommodation, and welcoming culture ease the stress of medical travel.
Structured follow-up at 1, 3, 6, and 12 months via secure video consultation tracks cognitive outcomes using standardised assessment tools, providing families with objective data on any changes following treatment.
Alternatives to Alzheimer's medication therapy
Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.
| Factor | Stem Cell Therapy | Conventional / Surgery |
|---|---|---|
| Typical Cost (Thailand) | $25,000 - $55,000 | N/A (no surgical equivalent) |
| Approach | Neuroprotective cell therapy | Cholinesterase inhibitors / memantine |
| Invasiveness | Minimally invasive infusion | Ongoing oral medication |
| Hospital Stay | Varies by protocol | Outpatient (ongoing prescriptions) |
| Risk Level | Low (cell-based, minimal side effects) | Low-Moderate (medication side effects) |
| Goal | Neuroprotection, cognitive support | Symptom management, slow progression |
Treatment at Boston Health Longevity
$25,000 - $55,000
USD equivalent, personalised to your case
vs Home Country
N/A (no surgical equivalent)
Internationally competitive pricing, same clinical standard
Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.
Wondering if you're a candidate?
Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.
Request AssessmentTrusted by international patients from 11+ countries worldwide
What to expect
Detailed remote consultation including family or carer involvement
Arrive in Chiang Mai with a companion, logistics support provided
Day 1: Comprehensive cognitive and neurological assessment
Day 2: Stem cell preparation and administration
Day 3-5: Monitoring, cognitive follow-up, and discharge
Structured remote follow-up with cognitive outcome tracking
Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →
Frequently Asked Questions
Can stem cell therapy reverse Alzheimer's disease?
Does the patient need to travel with a companion?
At what stage is treatment most appropriate?
How is progress measured after treatment?
Ready to explore alzheimer's & dementia treatment?
Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.
Most patients receive their initial assessment within 24 hours.
Submit Your Case
Share your medical history and imaging for review.
Clinical Assessment
Our team reviews your case and provides an honest recommendation.
Treatment Plan
Receive a personalised plan with transparent pricing.
Other conditions we treat
Related treatments & resources
Conditions We Treat
- Chronic Fatigue Syndrome
- Multiple Sclerosis
- Nerve Damage & Neuropathy
- Metabolic Syndrome
- Microvascular Dysfunction
- Muscle Strains & Tears
International Patients
Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Take the first step
Request a no-obligation assessment for alzheimer's & dementia treatment at Boston Health Longevity in Chiang Mai.
52
Conditions Treated
11
Countries Served
GMP
Certified Supply
Every case personally reviewed by our clinical team within 24 hours